Scoping review identifies AI tools for tobacco cessation, highlighting gaps in research and implementation.
Background: AI promises tailored tobacco cessation interventions but landscape is heterogeneous. Methods: Scoping review of PubMed, Scopus, Web of Science, Google Scholar (2000–April 2025) per Arksey & O’Malley framework. Included ML, NLP, chatbots, predictive models and apps. Results: Most work from high-income countries; common uses — quit prediction, relapse risk, chatbots, automated messaging. Limited evidence on integration into clinical settings, LMIC applicability, equity and privacy reporting. Conclusion: AI holds potential in cessation but requires robust effectiveness, equity and implementation research, especially in LMICs.
No takes yet. Share an insight, caveat, or question.
Mohanty et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: